| First Author | Yin KJ | Year | 2011 |
| Journal | Arterioscler Thromb Vasc Biol | Volume | 31 |
| Issue | 3 | Pages | 574-81 |
| PubMed ID | 21205987 | Mgi Jnum | J:184175 |
| Mgi Id | MGI:5320387 | Doi | 10.1161/ATVBAHA.110.221267 |
| Citation | Yin KJ, et al. (2011) Vascular PPARdelta protects against stroke-induced brain injury. Arterioscler Thromb Vasc Biol 31(3):574-81 |
| abstractText | OBJECTIVE: To investigate the effects of peroxisome proliferator-activated receptor (PPAR)delta in the cerebral vasculature following stroke-induced brain injury. METHODS AND RESULTS: Here, we report a novel finding that selective PPARdelta genetic deletion in vascular smooth muscle cells (VSMCs) resulted in increased cerebrovascular permeability and brain infarction in mice after middle cerebral artery occlusion (MCAO). Mechanistically, we revealed for the first time that PPARdelta expression is reduced, but matrix metalloproteinase (MMP)-9 activity is increased in cultured VSMCs after oxygen-glucose deprivation and also in the cerebral cortex of mice following MCAO. Moreover, gain- and loss of PPARdelta function in VSMCs significantly reduces and increases oxygen-glucose deprivation-induced MMP-9 activity, respectively. We have further identified that MMP-9 is a direct target of PPARdelta-mediated transrepression by chromatin immunoprecipitation and PPARdelta transcriptional activity assays. Furthermore, inhibition of MMP-9 activity by lentiviral MMP-9 short hairpin RNA effectively improves cerebrovascular permeability and reduces brain infarction in VSMC-selective PPARdelta conditional knockout mice after MCAO. CONCLUSIONS: Our data demonstrate that PPARdelta in VSMCs can prevent ischemic brain injury by inhibition of MMP-9 activation and attenuation of postischemic inflammation. The pharmacological activation of PPARdelta may provide a new therapeutic strategy to treat stroke-induced vascular and neuronal damage. |
